$0.8900
0.1926.29%
At close: Jun 10, 5:00 PM EST
$0.9211
0.03113.49%
After Hours: 7:59 PM EST
Outlook Therapeutics Inc Earnings Estimates
OTLKNASDAQ
Outlook Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OTLK
Outlook Therapeutics (OTLK) is scheduled to report Q3 earnings on August 13, 2026. Analysts estimate EPS of $-0.11 and quarterly revenue of $1.72M.
In the most recent quarter (Q2), Outlook Therapeutics reported EPS of $-0.16, missing estimates of $-0.12 by 0.33%. Revenue came in at $128.00K, missing the estimate of $4.40M by 0.97%.
Outlook Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Outlook Therapeutics has averaged an EPS surprise of 0.23% and a revenue surprise of 0.90%.
Earnings Date
Aug 13
EPS Estimate
$-0.110
Quarterly Revenue Estimate
$1.72M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$333.14K
Outlook Therapeutics Earnings History
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
Loading calendar...
Outlook Therapeutics (OTLK) Earnings Per Share
The chart below shows Outlook Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Outlook Therapeutics (OTLK) Revenue
The chart below shows Outlook Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics (OTLK) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 15, 2026 for Q2.
What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?
The Actual EPS was $-0.16, which missed the estimate of $-0.12.
What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?
The Actual Revenue was $128.00K, which missed the estimate of $4.40M.
